Clinical Trials
50
Participants
Discarded Bone Marrow for Hematology Research
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-10
Start Date:
2022-07-26
Completion:
2030-01-31
Conditions
Hemoglobinopathies
No Results Yet
183
Participants
ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2024-12-09
Completion:
2027-06-30
Conditions
Metastatic Prostate Cancer
Interventions
DRUG
No Results Yet
518
Participants
A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2020-12-07
Completion:
2026-12-30
Conditions
Urinary Bladder Neoplasms
Interventions
BIOLOGICAL
DRUG
RADIATION
No Results Yet
38
Participants
Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-10-21
Completion:
2025-12-03
Conditions
Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8
Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8
Stage IV Mycosis Fungoides and Sezary Syndrome AJCC v8
Interventions
PROCEDURE
DRUG
BIOLOGICAL
No Results Yet
177
Participants
A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2020-11-12
Completion:
2027-10-01
Conditions
Prostatic Neoplasms
Adenocarcinoma
Interventions
DRUG
RADIATION
No Results Yet
80
Participants
Comprehensive Esophageal Diagnostics Study
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-03-17
Completion:
2026-09-30
Conditions
Achalasia
Interventions
DRUG
PROCEDURE
No Results Yet
220
Participants
A Study of TAR-200 in Combination With Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Intravesical Bacillus Calmette-Guรฉrin Who Are Ineligible for or Elected Not to Undergo Radical Cystectomy
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2020-12-18
Completion:
2024-09-04
Conditions
Urinary Bladder Neoplasms
Interventions
DRUG
BIOLOGICAL
No Results Yet
310
Participants
Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-10
Start Date:
2020-01-09
Completion:
2027-04-11
Conditions
Endometrial Carcinoma
Malignant Uterine Neoplasm
Uterine Corpus Cancer
Uterine Corpus Sarcoma
Interventions
OTHER
No Results Yet
510
Participants
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-02-01
Completion:
2026-03-31
Conditions
Hematological Malignancies
Interventions
DRUG
No Results Yet
523
Participants
A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-01-06
Completion:
2026-02-27
Conditions
Alzheimer Disease
Cognitive Dysfunction
Dementia
Interventions
DRUG
No Results Yet
161
Participants
Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-01-26
Completion:
2026-12-31
Conditions
Melanoma
Non-small Cell Lung Cancer
Squamous Cell Carcinoma of the Head and Neck
Interventions
DRUG
No Results Yet
158
Participants
A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2020-11-10
Completion:
2024-07-11
Conditions
Advanced Solid Malignancies
Interventions
DRUG
No Results Yet
612
Participants
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2020-12-08
Completion:
2027-03-25
Conditions
Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer
Endometrial Cancer
Interventions
DRUG
No Results Yet
228
Participants
A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2020-12-15
Completion:
2025-03-18
Conditions
Multiple Myeloma
Interventions
DRUG
No Results Yet
55
Participants
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-05-21
Completion:
2026-12-31
Conditions
Metastatic Malignant Solid Neoplasm
Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma
Unresectable Malignant Solid Neoplasm
Interventions
PROCEDURE
DRUG
BIOLOGICAL
No Results Yet
12
Participants
Healthy Recovery After Trauma Study
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2020-09-10
Completion:
2026-11-30
Conditions
Stress Disorders, Post-Traumatic
Shame
Guilt
Sexual Assault and Rape
Interventions
BEHAVIORAL
No Results Yet
313
Participants
Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-09-27
Completion:
2024-01-16
Conditions
Depression, Anxiety
Engagement, Patient
Interventions
BEHAVIORAL
136
Participants
A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2020-11-13
Completion:
2021-10-15
Conditions
Prostatic Neoplasms
Interventions
DRUG
No Results Yet
40
Participants
Accuracy of the Dexcom G6 Continuous Glucose Monitoring System Following Cardiac Surgery
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-05-01
Completion:
2024-01-20
Conditions
Surgery--Complications
Interventions
DEVICE
3
Participants
LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-05-28
Completion:
2026-03-09
Conditions
Extensive Stage Lung Small Cell Carcinoma
Interventions
DRUG
No Results Yet
[Trial of device that is not approved or cleared by the U.S. FDA]
Last Updated:
2025-11-10
No Results Yet
194
Participants
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2020-09-17
Completion:
2025-11-30
Conditions
Hematological Malignancies
Interventions
DRUG
No Results Yet
694
Participants
A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2020-11-12
Completion:
2029-08-27
Conditions
Prostatic Neoplasms
Interventions
RADIATION
DRUG
No Results Yet
88
Participants
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2020-10-09
Completion:
2026-12-31
Conditions
Early-stage Breast Cancer
Hormone Receptor Positive Breast Carcinoma
Invasive Breast Cancer
Stage II Breast Cancer
Stage IIA Breast Cancer
Stage IIB Breast Cancer
Stage III Breast Cancer
Interventions
DRUG
PROCEDURE
BIOLOGICAL
No Results Yet
99
Participants
The Re-Prosper HF Study
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-06-09
Completion:
2025-12-31
Conditions
Heart Failure
Interventions
DRUG
No Results Yet
11
Participants
Neurofeedback-EEG-VR System for Non-opioid Pain Therapy
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-01-07
Completion:
2022-03-31
Conditions
Pain Management
Interventions
DEVICE
642
Participants
The Budesonide in Babies (BiB) Trial
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-04-01
Completion:
2024-09-05
Conditions
Bronchopulmonary Dysplasia (BPD)
Respiratory Distress Syndrome
Prematurity; Extreme
Neonatal
Interventions
DRUG
340
Participants
Trial of Therapeutic Hypothermia in Patients With ARDS
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-06-29
Completion:
2026-08-31
Conditions
Respiratory Distress Syndrome, Adult
Interventions
DEVICE
DRUG
No Results Yet
2753
Participants
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-01-21
Completion:
2033-12-31
Conditions
Prostate Adenocarcinoma
Stage III Prostate Cancer AJCC v8
Stage IVA Prostate Cancer AJCC v8
Interventions
DRUG
PROCEDURE
OTHER
RADIATION
No Results Yet
34
Participants
NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-02-10
Completion:
2026-03-31
Conditions
Recurrent Lung Non-Small Cell Carcinoma
Stage I Lung Cancer AJCC v8
Stage IA1 Lung Cancer AJCC v8
Stage IA2 Lung Cancer AJCC v8
Stage IA3 Lung Cancer AJCC v8
Stage IB Lung Cancer AJCC v8
Stage II Lung Cancer AJCC v8
Stage IIA Lung Cancer AJCC v8
Stage IIB Lung Cancer AJCC v8
Stage III Lung Cancer AJCC v8
Stage IIIA Lung Cancer AJCC v8
Stage IIIB Lung Cancer AJCC v8
Stage IIIC Lung Cancer AJCC v8
Unresectable Lung Non-Small Cell Carcinoma
Interventions
OTHER
RADIATION
No Results Yet
102
Participants
A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2020-10-07
Completion:
2023-06-12
Conditions
Triple-negative Breast Cancer
Non-squamous Non-small-cell Lung Cancer
NSCLC
Estrogen-receptor-positive Breast Cancer
Progesterone-receptor-positive Breast Cancer
Estrogen-receptor-negative Breast Cancer
ER-negative Breast Cancer
Progesterone-receptor Negative Breast Cancer
PR-negative Breast Cancer
HER2-negative Breast Cancer
ER-positive Breast Cancer
PR-positive Breast Cancer
Platinum-resistant Ovarian Cancer
Gastric Cancer
Pancreatic Cancer
Interventions
DRUG
96
Participants
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2020-11-16
Completion:
2029-02-28
Conditions
Open-angle Glaucoma
Ocular Hypertension
Interventions
DRUG
OTHER
No Results Yet
696
Participants
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2020-09-23
Completion:
2025-01-07
Conditions
Metastatic Castration-sensitive Prostate Cancer
Interventions
DRUG
No Results Yet
37
Participants
Study to Evaluate OXERVATEยฎ in Patients With Stage 1 Neurotrophic Keratitis
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2020-09-09
Completion:
2021-09-30
Conditions
Neurotrophic Keratitis
Interventions
DRUG
137
Participants
Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-03-30
Completion:
2023-03-10
Conditions
Non-small Cell Lung Cancer
Interventions
DRUG
180
Participants
Aspirin and Preeclampsia
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2021-02-15
Completion:
2026-03-01
Conditions
Preeclampsia Postpartum
Interventions
DRUG
No Results Yet
450
Participants
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
Study Type:
OBSERVATIONAL
Last Updated:
2025-11-10
Start Date:
2020-05-21
Completion:
2030-08-31
Conditions
Prostate Carcinoma
Interventions
PROCEDURE
OTHER
No Results Yet
107
Participants
AIM2: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2022-02-20
Completion:
2024-09-30
Conditions
Thyroid Nodules
Thyroid Cancer
Interventions
BEHAVIORAL
210
Participants
A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2020-10-08
Completion:
2022-11-16
Conditions
Paroxysmal Nocturnal Hemoglobinuria
Interventions
DRUG
2153
Participants
Reaching 90 90 90 in Adolescents in Zambia: Using All Our SKILLZ
Study Type:
INTERVENTIONAL
Last Updated:
2025-11-10
Start Date:
2020-02-01
Completion:
2022-12-31
Conditions
HIV Infections
Pregnancy Related
STI
Mental Health Wellness 1
Interventions
BEHAVIORAL
Showing 40 trials per page ยท Total 557382 trials